These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24947437)

  • 1. Optimization of impedance spectroscopy techniques for measuring cutaneous micropore formation after microneedle treatment in an elderly population.
    Kelchen MN; Holdren GO; Farley MJ; Zimmerman MB; Fairley JA; Brogden NK
    Pharm Res; 2014 Dec; 31(12):3478-86. PubMed ID: 24947437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of in vivo impedance spectroscopy techniques for measurement of micropore formation following microneedle insertion.
    Brogden NK; Ghosh P; Hardi L; Crofford LJ; Stinchcomb AL
    J Pharm Sci; 2013 Jun; 102(6):1948-1956. PubMed ID: 23589356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micropore closure kinetics are delayed following microneedle insertion in elderly subjects.
    Kelchen MN; Siefers KJ; Converse CC; Farley MJ; Holdren GO; Brogden NK
    J Control Release; 2016 Mar; 225():294-300. PubMed ID: 26829102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micropore Closure Rates following Microneedle Application at Various Anatomical Sites in Healthy Human Subjects.
    Ogunjimi AT; Lawson C; Carr J; Patel KK; Ferguson N; Brogden NK
    Skin Pharmacol Physiol; 2021; 34(4):214-228. PubMed ID: 33910205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micropore closure time is longer following microneedle application to skin of color.
    Ogunjimi AT; Carr J; Lawson C; Ferguson N; Brogden NK
    Sci Rep; 2020 Nov; 10(1):18963. PubMed ID: 33144596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans.
    Brogden NK; Banks SL; Crofford LJ; Stinchcomb AL
    Pharm Res; 2013 Aug; 30(8):1947-55. PubMed ID: 23761054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diclofenac delays micropore closure following microneedle treatment in human subjects.
    Brogden NK; Milewski M; Ghosh P; Hardi L; Crofford LJ; Stinchcomb AL
    J Control Release; 2012 Oct; 163(2):220-9. PubMed ID: 22929967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
    Yan G; Warner KS; Zhang J; Sharma S; Gale BK
    Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial skin barrier function recovery after microneedle transdermal delivery treatment.
    Han TY; Park KY; Ahn JY; Kim SW; Jung HJ; Kim BJ
    Dermatol Surg; 2012 Nov; 38(11):1816-22. PubMed ID: 22882208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of insulin using microneedle rollers in vivo.
    Zhou CP; Liu YL; Wang HL; Zhang PX; Zhang JL
    Int J Pharm; 2010 Jun; 392(1-2):127-33. PubMed ID: 20347024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo assessment of safety of microneedle arrays in human skin.
    Bal SM; Caussin J; Pavel S; Bouwstra JA
    Eur J Pharm Sci; 2008 Oct; 35(3):193-202. PubMed ID: 18657610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular effects of microneedle application.
    Hackethal J; Iredahl F; Henricson J; Anderson CD; Tesselaar E
    Skin Res Technol; 2021 Mar; 27(2):121-125. PubMed ID: 32662126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of Methotrexate and Characterization of Skin Treated by Fabricated PLGA Microneedles and Fractional Ablative Laser.
    Nguyen HX; Banga AK
    Pharm Res; 2018 Feb; 35(3):68. PubMed ID: 29468316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of skin resealing after insertion of microneedles in human subjects.
    Gupta J; Gill HS; Andrews SN; Prausnitz MR
    J Control Release; 2011 Sep; 154(2):148-55. PubMed ID: 21640148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss.
    Gomaa YA; Morrow DI; Garland MJ; Donnelly RF; El-Khordagui LK; Meidan VM
    Toxicol In Vitro; 2010 Oct; 24(7):1971-8. PubMed ID: 20732409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography.
    Coulman SA; Birchall JC; Alex A; Pearton M; Hofer B; O'Mahony C; Drexler W; Považay B
    Pharm Res; 2011 Jan; 28(1):66-81. PubMed ID: 20464461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.
    Milewski M; Brogden NK; Stinchcomb AL
    Expert Opin Drug Deliv; 2010 May; 7(5):617-29. PubMed ID: 20205604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
    Al-Qallaf B; Das DB
    Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced skin delivery of vismodegib by microneedle treatment.
    Nguyen HX; Banga AK
    Drug Deliv Transl Res; 2015 Aug; 5(4):407-23. PubMed ID: 26069156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.